JY, P., I, E., K, P., KM, R., M, A., DJ, E., & DJ, R. (2026). GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and Diabetes. Journal of general internal medicine. https://doi.org/10.1007/s11606-026-10515-2
Chicago Style (17th ed.) CitationJY, Pan, Elman I, Panchal K, Ramsey KM, Albanese M, Elman DJ, and Ramsey DJ. "GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and Diabetes." Journal of General Internal Medicine 2026. https://doi.org/10.1007/s11606-026-10515-2.
MLA (9th ed.) CitationJY, Pan, et al. "GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and Diabetes." Journal of General Internal Medicine, 2026, https://doi.org/10.1007/s11606-026-10515-2.